Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Early summer meningo encephalitis (TBE)

In the summer season the danger lurks almost everywhere

    • Education
    • General Internal Medicine
    • Infectiology
    • Prevention and health care
    • RX
  • 4 minute read

Since last year, with the exception of the cantons of Geneva and Ticino, the whole of Switzerland has been considered a TBE risk area. In the Swiss Vaccination Plan 2020, vaccination is recommended for all adults and children 6 years of age and older residing in the relevant regions. The risk group for a severe course with permanent damage or fatal consequences includes the age group over 60 years.

Tick-borne diseases are on the rise in Central Europe, with an increase in the number of cases in recent years. In Switzerland, the number of reported cases is between 100-300 annually [1]. Tick-borne diseases occur seasonally in this country. The season in which ticks are particularly active begins in March and ends in November, depending on the weather. Among the infectious diseases transmitted by ticks, Lyme disease and early summer meningoencephalitis (TBE) are of particular importance in our latitudes. The TBE virus is one of the human pathogenic flaviviruses.

Almost all of Switzerland is a risk area

In connection with a marked increase in cases of TBE in previous years, the FOPH has issued a warning against TBE infection from tick bites for the spring and summer months of 2019. With the exception of the cantons of Geneva and Ticino, the whole of Switzerland has been declared a risk area [2]. In the Swiss Vaccination Plan 2020, vaccination is recommended for all adults and children aged 6 years and older who reside or temporarily reside in a risk area [3]. The costs for these indications are covered by the health insurance (mandatory basic insurance). In children under 6 years of age, serious illnesses are rare, so the situation in children who are younger must be examined individually. Transmission occurs through infected ticks, approximately 1-10% are carriers of the virus [4]. TBE is one of the notifiable infectious diseases. From April to November, the FOPH publishes a situation report with the case numbers of early summer meningoencephalitis (TBE) in the first week of each month [5]. Diagnosis is serological by culture or sequence analysis (e.g. PCR, sequencing, NGS) or antibody detection (IgM, titer rise ≥4× or seroconversion).

Vaccination as the most important protective measure

In contrast to Lyme disease, there is currently no causal therapy for TBE in Switzerland, but a highly effective vaccination is available. The TBE vaccines approved in Switzerland are inactivated vaccines (killed viruses). The effect is supported by an aluminum salt. Three doses of vaccination are required for complete basic immunization (≥95% vaccine protection), and time-limited protection is achieved after only two doses of vaccination [2]. The specific vaccination schedule varies depending on the vaccine: when TBE-Immun® [12] is used, vaccinations are given at intervals of 0, 1 and 6 months. For Encepur® [14], the intervals are 0, 1 and 10 months. For both vaccines, a booster vaccination every 10 years is recommended in the Swiss Vaccination Plan 2020 [3]. Vaccination is possible at any time of year, but the preferred vaccination date for the first and second partial vaccinations is during the cold season so that vaccine protection is already in place at the onset of seasonal tick activity. The third partial vaccination should then take place in the spring of the following year. If basic immunization is not started until the warm season, a rapid immunization procedure can be used in which the 2nd partial vaccination is administered as early as 14 days after the first partial vaccination so that a protective antibody titer can be built up as quickly as possible [12]. The third dose should be given 5-12 months after the second vaccination. Whether or not a rapid immunization procedure should be used depends, among other things, on the availability of vaccines.

 

TBE: Biphasic course
When disease occurs, it usually progresses in two phases. After the bite of an infected tick, flu-like symptoms such as fever and headache and aching limbs initially develop within 2 to 28 days [13]. In 5-15% of affected individuals, meningitis or meningoencephalitis characterized by symptoms such as neck stiffness, clouding of consciousness, and paralysis occurs after another 4 to 6 days [13]. Residual symptoms may last weeks to months. In 1-2%, TBE with neurological symptoms is lethal; elderly persons and immunocompromised patients are particularly at risk for a severe course [1,7–9].

 

Risk group for severe course

Longer-term rehabilitation is required in >40% of TBE patients [6]. Risk factors for severe progression include immunosuppressive therapy, age >60 years, and male sex [7–9]. The prognosis of the meningitic course is best, with frequent inconsequential remission. In meningoencephalitis, neurasthenic symptoms may persist for several weeks and permanent sequelae occur in about 20% [10]. Encephalomyelitis has the worst prognosis. In an observational study over a ten-year period (n=57), only one-fifth of patients recovered completely, 50% retained permanent deficits, and 30% died as a result of the disease [11].

Literature:

  1. Federal Office of Public Health (FOPH): Notifiable infectious diseases 2020, www.bag.admin.ch
  2. Federal Office of Public Health (FOPH): Early summer meningoencephalitis (FSME). Bulletin 6/19; 12-14.  
  3. Federal Office of Public Health (FOPH): Swiss Vaccination Plan 2020, www.bag.admin.ch
  4. Krause M: Lyme disease and TBE. Slide presentation, Prof. Martin Krause, MD. FOMF WebUp, Zurich, 16.05.2020.
  5. Federal Office of Public Health (FOPH):  Tick-borne diseases, www.bag.admin.ch/bag/de/home/krankheiten
  6. Karelis G, et al: Tick-borne encephalitis in Latvia 1973-2009: epidemiology, clinical features and sequelae. Eur J Neurol 2012; 19: 62-68.
  7. Czupryna P, et al: Sequelae of tick-borne encephalitis in retrospective analysis of 1072 patients. Epidemiol Infect 2018; 146: 1663-1670.
  8. Lenhard T, et al: Predictors, Neuroimaging Characteristics and Long-Term Outcome of Secere European Tick-Borne Encephalitis: A Prospective Cohort Study. PLoS One 2016; 11: e0154153.
  9. German Society of Neurology (DGN): S1 Guideline Early Summer Meningoencephalitis  (FSME) 2020, www.awmf.org
  10. Bogovic P, et al: The long-term outcome of tick-borne encephalitis in Central Europe. Ticks Tick Borne Dis 2018; 9: 369-378.
  11. Kaiser R: Long-term prognosis of patients with primary myelitic manifestation of tick-borne encephalitis: a trend analysis covering 10 years. Neurologist 2011; 82: 1020-1025.
  12. Swiss Drug Compendium: FSME-Immun®, https://compendium.ch
  13. Infovac.ch www.infovac.ch
  14. Swiss Drug Compendium: Encepur®, https://compendium.ch

 

GP PRACTICE 2020; 15(6): 24

Autoren
  • Mirjam Peter, M.Sc.
Publikation
  • HAUSARZT PRAXIS
Related Topics
  • TBE
  • ticks
Previous Article
  • Precision Oncology

First drug with tumor-independent indication approved

  • Market & Medicine
  • Oncology
  • RX
  • Studies
View Post
Next Article
  • September

Migraine and Headache Awareness Month

  • Neurology
  • News
  • RX
View Post
You May Also Like
View Post
  • 11 min
  • Findings from the ALS Symposium 2024 in Montreal

Current and future approaches in the treatment of amyotrophic lateral sclerosis (ALS)

    • Congress Reports
    • Interviews
    • Neurology
    • RX
    • Studies
View Post
  • 8 min
  • Efficacy, mechanism of action and clinical effects

Garlic and high blood pressure

    • Cardiology
    • Education
    • General Internal Medicine
    • Pharmaceutical medicine
    • Phytotherapy
    • RX
    • Studies
View Post
  • 7 min
  • Moderate to severe chronic hand eczema

Delgocitinib cream – first topical pan-JAK inhibitor approved in Switzerland

    • Allergology and clinical immunology
    • Dermatology and venereology
    • Education
    • Infectiology
    • Market & Medicine
    • Pharmacology and toxicology
    • RX
View Post
  • 9 min
  • Wild-type transthyretin amyloid cardiomyopathy (ATTRwt-CA)

Diagnosis at an early stage, prognostic classifications and outlook

    • Cardiology
    • Education
    • RX
    • Studies
View Post
  • 4 min
  • Case report: Drug-induced hepatitis

Rare side effect of tirzepatide therapy

    • Cases
    • Education
    • Endocrinology and Diabetology
    • Gastroenterology and Hepatology
    • Pharmacology and toxicology
    • RX
    • Studies
View Post
  • 4 min
  • Plea for sex-specific neurology

Migraine in men: underdiagnosed, underestimated, under-researched

    • Education
    • Neurology
    • RX
    • Studies
View Post
  • 4 min
  • Prurigo nodularis

Retrospective analyses of large data sets from everyday practice

    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • RX
View Post
  • 3 min
  • Public Health

Outpatient care in Switzerland: situation report

    • General Internal Medicine
    • Practice Management
    • Prevention and health care
    • RX
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
  • Dermatology News

    Zum Thema
Top CME content
  • 1
    Patience, knowledge and persistence in therapy
  • 2
    Sarcopenia and malnutrition in the context of pneumological rehabilitation
  • 3
    Medical and psychosocial perspectives
  • 4
    New nomenclature for non-alcoholic fatty liver disease
  • 5
    Examinations and considerations before therapy

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.